4//SEC Filing
Young Richard A 4
Accession 0000950170-24-107862
CIK 0001556263other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:00 PM ET
Size
7.0 KB
Accession
0000950170-24-107862
Insider Transaction Report
Form 4
Young Richard A
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-09-16−2,667→ 2,667 total→ Common Stock (2,667 underlying) - Exercise/Conversion
Common Stock
2024-09-16+2,667→ 10,667 total
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit ("RSU") award
- [F2]Each RSU represents the contingent right to receive one share of the issuer's common stock.
- [F3]Represents a restricted stock unit award granted on September 16, 2022. These restricted stock units vest in three equal annual installments commencing on September 16, 2023.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001490283
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 5:00 PM ET
- Size
- 7.0 KB